MONG-WEI LINYang P.-W.JANG-MING LEE2021-10-082021-10-0820162072-1439https://www.scopus.com/inward/record.uri?eid=2-s2.0-84990229679&doi=10.21037%2fjtd.2016.07.95&partnerID=40&md5=2d672b4f1d1a4fe50c550111c62a0e3chttps://scholars.lib.ntu.edu.tw/handle/123456789/584345Thoracic surgeons should be more aware of the latest information about histopathological, genetic and epigenetic alterations that may influence treatment policy and patient outcome in the biomolecular era. Translational research studies often produce a promising diagnostic tool or new treatment that can be used clinically. The results of these translational studies may even change the practical guidelines and current staging system in thoracic malignancies. The following article summarizes the experiences of translational research in esophageal cancer and non-small cell lung cancer (NSCLC) at National Taiwan University Hospital in Taiwan. ? Journal of Thoracic Disease.[SDGs]SDG3automation; clinical decision support system; closed loop medication administration; drug administration; electronic medical record system; health care quality; health care system; hospital care; hospital information system; human; medical device; medical informatics; methodology; patient care; patient participation; patient safety; personal experience; radiofrequency identification; Review; smartphone; South Korea; tertiary care center; university hospital; workflowreview10.21037/jtd.2016.07.952-s2.0-84990229679